Position in GILD
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$399,360
-$40,491 QoQ
Shares Held
3,161
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,495
of 2,266 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Callahan Advisors, LLC holds $70,085,621 across 7 Drug Manufacturers - General names. GILD ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
106,466 | $27,039,170 | |
| 2 | LLY |
ELI LILLY & Co
|
21,791 | $26,136,781 | |
| 3 | PFE |
Pfizer Inc
|
471,052 | $11,342,932 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,700 | $2,916,950 | |
| 5 | ABBV |
AbbVie Inc.
|
5,488 | $1,381,000 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,089 | $869,428 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
3,161 | $399,360 |
All Filings in GILD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $399,360 | 3,161 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $439,851 | 3,156 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $386,876 | 3,152 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $349,317 | 3,147 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $348,353 | 3,142 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $520,808 | 4,648 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $604,099 | 6,540 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $262,000 | 3,125 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $282,604 | 4,119 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $227,880 | 3,111 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $251,374 | 3,103 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $232,089 | 3,097 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $238,146 | 3,090 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $297,281 | 3,583 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $319,962 | 3,727 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $228,253 | 3,700 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $228,140 | 3,691 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $218,894 | 3,682 | Shares | Sole | 2022-04-27 | |
| 2021-09-30 | $200,120 | 2,865 | Shares | Sole | 2021-11-03 | |
| 2020-12-31 | $223,893 | 3,843 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $229,758 | 3,636 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $328,072 | 4,264 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $345,615 | 4,623 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||